Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23155Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sioka, C. | en |
| dc.contributor.author | Kyritsis, A. P. | en |
| dc.date.accessioned | 2015-11-24T19:30:43Z | - |
| dc.date.available | 2015-11-24T19:30:43Z | - |
| dc.identifier.issn | 0167-594X | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23155 | - |
| dc.rights | Default Licence | - |
| dc.subject | Antineoplastic Agents/*therapeutic use | en |
| dc.subject | Antineoplastic Agents, Hormonal/therapeutic use | en |
| dc.subject | Clinical Trials as Topic | en |
| dc.subject | Humans | en |
| dc.subject | Immunotherapy/*methods | en |
| dc.subject | Meningeal Neoplasms/*therapy | en |
| dc.subject | Meningioma/*therapy | en |
| dc.subject | Neoplasm Recurrence, Local/*therapy | en |
| dc.title | Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1007/s11060-008-9734-y | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19023520 | - |
| heal.identifier.secondary | http://www.springerlink.com/content/9p637474h85g5821/fulltext.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2009 | - |
| heal.abstract | Meningioma is a common intracranial tumor, originating from the meninges of the skull or spinal canal. Most meningiomas are benign tumors, however atypical or anaplastic tumors can be found in 6% of cases. Patients with asymptomatic small benign meningiomas can be followed without therapy, but in symptomatic patients complete surgical resection should be performed. For recurrent previously resected tumors re-resection is recommended followed by radiotherapy in selected cases. Antiprogesterone treatment can also be considered in recurrent benign meningiomas. Immunotherapy with interferon-alpha and chemotherapy should be reserved for all cases of recurrent meningiomas (benign, atypical, and malignant) when all the standard therapies have failed or contraindicated. | en |
| heal.journalName | J Neurooncol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Sioka-2009-Chemotherapy, hormon.pdf | 147.84 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
